Trade HOWL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Werewolf Therapeutics, Inc. (HOWL) is trading at US$0.97, down 0.49% today as of Aug 28, 09:49 EDT. The company has a market capitalisation of US$42.45M. Over the past 52 weeks, HOWL has traded between US$0.27 and US$2.38. On Syfe you can trade HOWL with $0 commission and add it to your watchlist.
| Previous close | US$0.97 |
|---|---|
| Market cap | US$42.45M |
| 52-week range | US$0.27 – US$2.38 |
| Volume | 2.19M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.
Year: 2021
Werewolf Therapeutics Insider Sold Shares Worth $280,210, According to a Recent SEC Filing
May 13, 8:54 AM · MT Newswires
Werewolf Therapeutics, Inc. (HOWL) stock is trading at US$0.97, -0.49% from the previous close of US$0.97.
The market cap for Werewolf Therapeutics, Inc. (HOWL) stock is approximately US$42.45M.
The 52-week high for Werewolf Therapeutics, Inc. (HOWL) stock is US$2.38.
The 52-week low for Werewolf Therapeutics, Inc. (HOWL) stock is US$0.27.
Werewolf Therapeutics, Inc. (HOWL) does not currently pay a dividend.
Stay on top of HOWL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
